최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.25 no.12 = no.188, 2015년, pp.1425 - 1431
김하정 (경북대학교 의학전문대학원 생리학교실)
The lymphocyte component of the immune system is divided into B lymphocytes and T lymphocytes. B lymphocytes produce antibodies (humoral immunity) via maturation into plasma cells, and T lymphocytes kill other cells or organisms (cellular immunity). A traditional immunological paradigm is that B lym...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Agarwal, A., Verma, S., Burra, U., Murthy, N. S., Mohanty, N. K. and Saxena, S. 2006. Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder. Cancer Immunol. Immunother. 55, 734- 743.
Aste-Amezaga, M., Ma, X., Sartori, A. and Trinchieri, G., 1998. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160, 5936-5944.
Barbera-Guillem, E., Nelson, M. B., Barr, B., Nyhus, J. K., May, K. F. Jr, Feng, L. and Sampsel, J. W. 2000. B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion. Cancer Immunol. Immunother. 48, 541-549.
Chapoval, A. I., Fuller, J. A., Kremlev, S. G., Kamdar, S. J. and Evans, R. 1998. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. J. Immunol. 161, 6977-6984.
Chung, C. Y., Ysebaert, D., Berneman, Z. N. and Cools, N. 2013. Dendritic cells: cellular mediators for immunological tolerance. Clin. Dev. Immunol. 2013, 972865.
Del Vecchio, M., Bajetta, E., Canova, S., Lotze, M. T., Wesa, A., Parminani, G. and Anichini, A. 2007. Interleukin-12: biological properties and clinical application. Clin. Cancer Res. 13, 4677-4685.
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoue, F., Bruneval, P., Cugnenc, P. H., Trajanoski, Z., Fridman, W. H. and Pages, F. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964.
Houbiers, J. G., van der Burg, S. H., van de Watering, L. M., Tollenaar, R. A., Rrand, A., van de Velde, C. J. and Melief, C. J. 1995. Antibodies against p53 are associated with poor prognosis of colorectal cancer. Br. J. Cancer 72, 637-641.
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D. and Levitsky, H. 1998. The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med. 188, 2357-2368.
Kanazawa, M., Yoshihara, K., Abe, H., Iwadate, M., Watanabe, K., Suzuki, S., Endoh, Y., Takita, K., Sekikawa, K., Takenochita, S., Ogata, T. and Ohto, H. 2005. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients. Anticancer Res. 25, 443-449.
Kim, S., Elkon, K. B. and Ma, X. 2004. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21, 643-653.
Ma, X., Sun, J., Papasavvas, E., Riemann, H., Robertson, S., Marchall, J., Bailer, R. T., Moore, A., Donnelly, R. P., Trinchieri, G. and Montaner, L. J. 2000. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J. Immunol. 164, 1722-1729.
Mitsuhashi, M., Liu, J., Cao, S., Shi, X. and Ma, X. 2004. Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J. Leukoc. Biol. 76, 322-332
Perricone, M. A., Smith, K. A., Claussen, K. A., Plog, M. S., Hempel, D. M., Roberts, B. L., St George, J. A. and Kaplan, J. M. 2004. Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes. J. Immunother. 27, 273-281.
Rosser, E. C. and Mauri, C. 2015. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607-612
Rowley, D. A. and Stach, R. M. 1998. B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses. Int. Immunol. 10, 355-363.
Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H. M., Newman, C. L., Shin, S. U., Nechustan, H., Challita-Eid, P. M., Segal, B. M., Yi, K. H. and Rosenblatt, J. D. 2005. Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. Int. J. Cancer 117, 574-586.
Sheu, B. C., Lin, R. H., Lien, H. C., Ho, H. N., Hsu, S. M. and Huang, S. C. 2001. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J. Immunol. 167, 2972-2978.
Silverstein, A. M. 2003. Cellular versus humoral immunology: a century-long dispute. Nat. Immunol. 4, 425-428.
Tangye, S. G., Ma, C. S., Brink, R. and Deenick, E. K. 2013. The good, the bad and the ugly - TFH cells in human health and disease. Nat. Rev. Immunol. 13, 412-426.
Tatsumi, T., Huang, J., Gooding, W. E., Gambotto, A., Tatsumi, T., Huang, J., Gooding, W. E., Gambotto, A., Robbins, P. D., Vujuanovic, N. L., Alber, S. M., Watkins, S. C., Okada, H. and Storkus, W. J. 2003. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity. Cancer Res. 63, 6378-6386.
van Herpen, C. M., Looman, M., Zonneveld, M., Scharenborg, N., de Wilde, P. C., van de Locht, L., Merkx, M. A., Adema, G. J. and de Mulder, P. H. 2004. Intratumoral administration of recombinant human interleukin 12 in head and neck squamous cell carcinoma patients elicits a T-helper 1 profile in the locoregional lymph nodes. Clin. Cancer Res. 10, 2626-2635.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.